News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
GSK announces expanded collaboration with Tempus in precision medicine to accelerate R&D
Wednesday, October 19, 2022GSK plc and Tempus a USbased precision medicine company have entered into a threeyear collaboration agreement that provides GSK with access to Tempus AIenabled platform including its library of deidentified patient data Through its leading Artificial...
SHINE Gets Dutch Approval for Project to Improve Patient Access to Promising New Nuclear Medicine
Tuesday, October 18, 2022SHINE Technologies a nextgeneration fusion technology company and SHINE Europe announced today that the Dutch government has approved a substantial grant proposal to develop a plan to produce a variety of terbium isotopes for use in nuclear medicine...
Exacis Biotherapeutics Grants Eterna Therapeutics an Option to License Up To Four Allogeneic Ipsc-derived NK And T Cell Therapies
Tuesday, October 18, 2022Exacis Biotherapeutics Inc a developmentstage immunooncology company working to harness the immune system to cure cancer today announced that it has signed an option agreement with Eterna Therapeutics Inc Eterna providing Eterna the right to license...
BeiGene Receives Positive CHMP Opinion for BRUKINSA® (zanubrutinib) for the Treatment of Adults With CLL
Saturday, October 15, 2022BeiGene a global biotechnology company focused on developing innovative and affordable oncology medicines to improve treatment outcomes and access for patients worldwide today announced that the Committee for Medicinal Products for Human Use CHMP of...
Emergex Acquires Intradermal and Patch Drug Delivery Technology with Its Manufacturing Equipment from Zosano Pharma
Thursday, October 13, 2022Emergex Vaccines Holding Limited a clinical stage biotechnology company addressing major global infectious diseases through the development of fully synthetic CD T cell Adaptive Vaccines announces that it has acquired the assets of Zosano Pharma Corp...
TILT Biotherapeutics Announces First US Patient Dosed in Immunotherapy Clinical Trial in Ovarian Cancer
Wednesday, October 12, 2022TILT Biotherapeutics a clinicalstage biotechnology company developing cancer immunotherapies announces that the first US patient has been dosed in its ovarian cancer trial NCT using its oncolytic adenovirus TILT that has the potential to be firstincl...
LabVantage Solutions and Biomax Informatics Merge to Create Innovative Capabilities for the Life Science and Bio Manufacturing Industries
Wednesday, October 12, 2022LabVantage Solutions Inc the leading provider of laboratory informatics solutions and services including purposebuilt LIMS solutions that allow labs to go live faster and at a lower total cost and Biomax Informatics AG a software solutions and servic...
BIOCORP and Merck KGaA, Darmstadt, Germany, Sign a New Partnership for Smart Drug Delivery
Tuesday, October 11, 2022BIOCORP a French company specialized in the design development and manufacturing of innovative medical devices and Merck KGaA Darmstadt Germany a leading science and technology company have entered into an agreement for the development and supply of...
STALICLA to in-license SFX-01 from Evgen for neurodevelopment disorder indications
Tuesday, October 11, 2022STALICLA SA a precision neuroscience clinical stage biotech advancing the first precision medicine platform DEPI for patients with Neurodevelopmental Disorders NDDs today announced the worldwide inlicensing of SFX from Evgen Pharma plc Evgen in neuro...
Dipharma Receives Regulatory Authorization for the New Line at Its cGMP Pilot Plant
Friday, October 07, 2022Dipharma Francis Srl a leading Contract Development and Manufacturing Organization CDMO and a global manufacturer of Active Pharmaceutical Ingredients announced today that the Italian Medicines Agency AIFA approved the brandnew production line at the...
